Company intelligence / Profile preview

Alcaliber

Madrid, Comunidad de Madrid, Spainalcaliber.com ↗

Ownership: Private
Development stage: Other

Overview

Alcaliber operates at commercial scale as a global leader in the production of narcotic raw materials and active pharmaceutical ingredients derived from poppy extracts. It supplies a significant share of the world’s morphine and thebaine for pharmaceutical use. No clinical trial results are reported as it does not develop finished drugs but manufactures regulated APIs for pharma clients.

Therapeutic areas: Neurology
Modalities: Small moleculeAlkaloids (derived from poppy extracts)Narcotic raw materials (opioid alkaloids)
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Alcaliber.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alcaliber.

Explore the full profile